Li F P, Yan J C, Sallan S, Cassady J R, Danahy J, Fine W, Gelber R D, Green D M
J Natl Cancer Inst. 1983 Dec;71(6):1205-9.
The frequency of second neoplasms was examined among 487 Wilms' tumor patients treated at the Dana-Farber Cancer Institute and Children's Hospital of Boston, 1927-81. Thirty study patients (6%) developed second primary tumors: 11 cancers, 16 benign tumors, and 3 borderline neoplasms. Cumulative probability of a second cancer was 18% (standard error, 6%) in 34 years after diagnosis of Wilms' tumor. The subgroup of 412 patients who had received radiotherapy for Wilms' tumor developed all 11 second cancers, which included 1 skin carcinoma, 1 acute leukemia, and 9 solid internal cancers (expected, 0.7 cancers other than skin carcinoma; P less than .001). After exclusion of the secondary leukemia, all but 1 second cancer arose within the radiotherapy field. Concurrent therapy with dactinomycin did not reduce the risk of a radiation-associated cancer. Second cancer was the cause of death in 7 patients.
对1927年至1981年间在丹娜法伯癌症研究所和波士顿儿童医院接受治疗的487例威尔姆斯瘤患者的第二肿瘤发生频率进行了研究。30例研究患者(6%)发生了第二原发性肿瘤:11例癌症、16例良性肿瘤和3例交界性肿瘤。威尔姆斯瘤诊断后34年,第二癌症的累积概率为18%(标准误差为6%)。因威尔姆斯瘤接受放疗的412例患者亚组发生了全部11例第二癌症,其中包括1例皮肤癌、1例急性白血病和9例实体内部癌症(预期除皮肤癌外有0.7例癌症;P<0.001)。排除继发性白血病后,除1例第二癌症外,其余均发生在放疗野内。与放线菌素同时治疗并未降低辐射相关癌症的风险。第二癌症是7例患者的死亡原因。